Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    January 2017
  1. YAMASHITA S, Odisio BC, Huang SY, Kopetz SE, et al
    Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30057.
    PubMed     Text format     Abstract available


    December 2016
  2. NANJI S, Tsang ME, Wei X, Booth CM, et al
    Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases.
    Eur J Surg Oncol. 2016 Dec 13. pii: S0748-7983(16)31035.
    PubMed     Text format     Abstract available


    October 2016
  3. GHANIPOUR L, Jirstrom K, Sundstrom M, Glimelius B, et al
    Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 31. pii: S0748-7983(16)30951.
    PubMed     Text format     Abstract available


  4. LEUNG V, Huo YR, Liauw W, Morris DL, et al
    Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
    Eur J Surg Oncol. 2016 Oct 13. pii: S0748-7983(16)30929.
    PubMed     Text format     Abstract available


  5. LORIMIER G, Linot B, Paillocher N, Dupoiron D, et al
    Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Eur J Surg Oncol. 2016 Oct 7. pii: S0748-7983(16)30899.
    PubMed     Text format     Abstract available


  6. MACIVER AH, Lee N, Skitzki JJ, Boland PM, et al
    Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms.
    Eur J Surg Oncol. 2016 Oct 3. pii: S0748-7983(16)30901.
    PubMed     Text format     Abstract available


    September 2016
  7. KRISHNAMURTHY A, Kankesan J, Wei X, Nanji S, et al
    Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30888.
    PubMed     Text format     Abstract available


    August 2016
  8. WIELDRAAIJER T, Duineveld LA, van Asselt KM, van Geloven AA, et al
    Follow-up of colon cancer patients; causes of distress and need for supportive care: Results from the ICARE Cohort Study.
    Eur J Surg Oncol. 2016 Aug 31. pii: S0748-7983(16)30856.
    PubMed     Text format     Abstract available


  9. JONES RP, Malik HZ, Fenwick SW, Terlizzo M, et al
    PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Eur J Surg Oncol. 2016 Aug 10. pii: S0748-7983(16)30837.
    PubMed     Text format     Abstract available


    July 2016
  10. KENNELLY RP, Gryfe R, Winter DC
    Familial colorectal cancer: Patient assessment, surveillance and surgical management.
    Eur J Surg Oncol. 2016 Jul 27. pii: S0748-7983(16)30675.
    PubMed     Text format     Abstract available


    June 2016
  11. MARGADANT CC, Bruns ER, Sloothaak DA, van Duijvendijk P, et al
    Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30592.
    PubMed     Text format     Abstract available


  12. KOHNE CH, Poston G, Folprecht G, Ciardiello F, et al
    FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
    Eur J Surg Oncol. 2016 Jun 23. pii: S0748-7983(16)30587.
    PubMed     Text format     Abstract available


  13. MOHAN HM, Ryan E, Balasubramanian I, Kennelly R, et al
    Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Eur J Surg Oncol. 2016 Jun 22. pii: S0748-7983(16)30164.
    PubMed     Text format     Abstract available


  14. CHOLANKERIL G, Hu M, Tanner E, Cholankeril R, et al
    Skilled nursing facility placement in hospitalized elderly patients with colon cancer.
    Eur J Surg Oncol. 2016 Jun 17. pii: S0748-7983(16)30199.
    PubMed     Text format     Abstract available


  15. REIMA H, Saar H, Innos K, Soplepmann J, et al
    Methylene blue intra-arterial staining of resected colorectal cancer specimens improves accuracy of nodal staging: A randomized controlled trial.
    Eur J Surg Oncol. 2016 Jun 16. pii: S0748-7983(16)30187.
    PubMed     Text format     Abstract available


    May 2016
  16. RIBEIRO GOMES J, Belotto M, D'Alpino Peixoto R
    The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature.
    Eur J Surg Oncol. 2016 May 30. pii: S0748-7983(16)30170.
    PubMed     Text format     Abstract available


  17. PIEGELER T, Beck-Schimmer B
    Anesthesia and colorectal cancer - The perioperative period as a window of opportunity?
    Eur J Surg Oncol. 2016 May 24. pii: S0748-7983(16)30154.
    PubMed     Text format     Abstract available


  18. MONTRONI I, Wexner SD
    Robotic colorectal cancer surgery: Are data supporting the desire to innovate?
    Eur J Surg Oncol. 2016 May 21. pii: S0748-7983(16)30152.
    PubMed     Text format    


  19. MARTINS J, Alexandrino H, Oliveira R, Cipriano MA, et al
    Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Eur J Surg Oncol. 2016;42:713-21.
    PubMed     Text format     Abstract available


    April 2016
  20. GERVAZ P, Usel M, Rapiti E, Chappuis P, et al
    Right colon cancer: Left behind.
    Eur J Surg Oncol. 2016 Apr 23. pii: S0748-7983(16)30057.
    PubMed     Text format     Abstract available


  21. THILLAI K, Repana D, Korantzis I, Kane P, et al
    Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30049.
    PubMed     Text format     Abstract available


  22. PEDZIWIATR M, Pisarska M, Major P, Grochowska A, et al
    Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30055.
    PubMed     Text format     Abstract available


  23. VAN AMERONGEN MJ, van der Stok EP, Futterer JJ, Jenniskens SF, et al
    Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
    Eur J Surg Oncol. 2016;42:523-30.
    PubMed     Text format     Abstract available


  24. LYKKE J, Jess P, Roikjaer O
    The prognostic value of lymph node ratio in a national cohort of rectal cancer patients.
    Eur J Surg Oncol. 2016;42:504-12.
    PubMed     Text format     Abstract available


  25. BJORNSSON B, Sparrelid E, Rosok B, Pomianowska E, et al
    Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Eur J Surg Oncol. 2016;42:531-7.
    PubMed     Text format     Abstract available


    March 2016
  26. JEUNE F, Brouquet A, Caramella C, Gayet M, et al
    Cardiophrenic angle lymph node is an indicator of metastatic spread but not specifically peritoneal carcinomatosis in colorectal cancer patients: Results of a prospective validation study in 91 patients.
    Eur J Surg Oncol. 2016 Mar 10. pii: S0748-7983(16)00374.
    PubMed     Text format     Abstract available


  27. WIGGANS MG, Shahtahmassebi G, Aroori S, Bowles MJ, et al
    The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Eur J Surg Oncol. 2016;42:426-32.
    PubMed     Text format     Abstract available


    February 2016
  28. SERRABLO A, Paliogiannis P, Pulighe F, Moro SS, et al
    Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.
    Eur J Surg Oncol. 2016 Feb 23. pii: S0748-7983(16)00107.
    PubMed     Text format     Abstract available


  29. TANIS E, Spliethoff JW, Evers DJ, Langhout GC, et al
    Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.
    Eur J Surg Oncol. 2016;42:251-9.
    PubMed     Text format     Abstract available


  30. GHIGNONE F, van Leeuwen BL, Montroni I, Huisman MG, et al
    The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons' attitudes.
    Eur J Surg Oncol. 2016;42:297-302.
    PubMed     Text format     Abstract available


  31. LLADO L, Munoz A, Ramos E, Torras J, et al
    The anterior hanging-approach improves postoperative course after right hepatectomy in patients with colorectal liver metastases. Results of a prospective study with propensity-score matching comparison.
    Eur J Surg Oncol. 2016;42:176-83.
    PubMed     Text format     Abstract available


  32. TAKATSUKI M, Tokunaga S, Uchida S, Sakoda M, et al
    Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
    Eur J Surg Oncol. 2016;42:184-9.
    PubMed     Text format     Abstract available


  33. VERMEER TA, Orsini RG, Nieuwenhuijzen GA, Rutten HJ, et al
    Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline.
    Eur J Surg Oncol. 2016;42:273-80.
    PubMed     Text format     Abstract available


  34. RUPINSKI M, Szczepkowski M, Malinowska M, Mroz A, et al
    Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
    Eur J Surg Oncol. 2016;42:288-96.
    PubMed     Text format     Abstract available


  35. KUIJPERS AM, Hauptmann M, Aalbers AG, Nienhuijs SW, et al
    Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
    Eur J Surg Oncol. 2016;42:244-50.
    PubMed     Text format     Abstract available


  36. BOUHADJARI N, Gabato W, Calabrese D, Msika S, et al
    Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
    Eur J Surg Oncol. 2016;42:219-23.
    PubMed     Text format     Abstract available


    January 2016
  37. ZIELINSKI M, Zaimi R, Sabatier P, Bagan P, et al
    Is radiofrequency ablation of lung metastases the most radical treatment?
    Eur J Surg Oncol. 2016;42:149-50.
    PubMed     Text format    


    December 2015
  38. TREASURE T, Macbeth F
    Percutaneous Image Guided Thermal Ablation (IGTA) therapies are to be included in the interventional arm of the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) trial to test if survival and quality of life are better than with intention to tre
    Eur J Surg Oncol. 2015 Dec 23. pii: S0748-7983(15)00925.
    PubMed     Text format    


  39. BALTATZIS M, Chan AK, Jegatheeswaran S, Mason JM, et al
    Colorectal cancer with synchronous hepatic metastases: Systematic review of reports comparing synchronous surgery with sequential bowel-first or liver-first approaches.
    Eur J Surg Oncol. 2015 Dec 20. pii: S0748-7983(15)00841.
    PubMed     Text format     Abstract available


  40. STRACCI F, Bianconi F, Leite S, Liso A, et al
    Linking surgical specimen length and examined lymph nodes in colorectal cancer patients.
    Eur J Surg Oncol. 2015 Dec 17. pii: S0748-7983(15)00898.
    PubMed     Text format     Abstract available


  41. PATHAK S, Nunes QM, Daniels IR, Smart NJ, et al
    Rectal cancer with synchronous liver metastases: Do we have a clear direction?
    Eur J Surg Oncol. 2015;41:1570-7.
    PubMed     Text format     Abstract available


  42. BEETS GL, Figueiredo NL, Habr-Gama A, van de Velde CJ, et al
    A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD).
    Eur J Surg Oncol. 2015;41:1562-4.
    PubMed     Text format    


  43. DENOST Q, Faucheron JL, Lefevre JH, Panis Y, et al
    French current management and oncological results of locally recurrent rectal cancer.
    Eur J Surg Oncol. 2015;41:1645-52.
    PubMed     Text format     Abstract available


  44. EVRARD S
    In favour of One-Stage Strategy (OSS).
    Eur J Surg Oncol. 2015;41:1568-9.
    PubMed     Text format    


  45. VAN ERNING FN, Rutten HJ, van den Berg HA, Lemmens VE, et al
    Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
    Eur J Surg Oncol. 2015;41:1630-5.
    PubMed     Text format     Abstract available


  46. KRAIMA AC, West NP, Treanor D, Magee DR, et al
    Understanding the surgical pitfalls in total mesorectal excision: Investigating the histology of the perirectal fascia and the pelvic autonomic nerves.
    Eur J Surg Oncol. 2015;41:1621-9.
    PubMed     Text format     Abstract available



  47. Advanced colorectal liver metastases: One or two-stage strategies?
    Eur J Surg Oncol. 2015;41:1565.
    PubMed     Text format    


  48. PASSOT G, Vauthey JN
    In favor of two-stage hepatectomy (TSH).
    Eur J Surg Oncol. 2015;41:1566-7.
    PubMed     Text format    


    November 2015
  49. BARAT M, Soyer P, Eveno C, Dautry R, et al
    The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: Results of a case-control study.
    Eur J Surg Oncol. 2015 Nov 27. pii: S0748-7983(15)00892.
    PubMed     Text format     Abstract available


  50. VERBERNE CJ, Wiggers T
    Reply to: Is there survival benefit from increased intensity for CEA monitoring after primary resection of colorectal cancer?
    Eur J Surg Oncol. 2015 Nov 5. pii: S0748-7983(15)00829.
    PubMed     Text format    


  51. TREASURE T, Macbeth F
    Is there a survival benefit from increased intensity of CEA monitoring after primary resection of colorectal cancer?
    Eur J Surg Oncol. 2015 Nov 2. pii: S0748-7983(15)00830.
    PubMed     Text format    


  52. ETTORRE GM, Guglielmo N, Felli E, Meniconi RL, et al
    Is there still a room to improve the safety of ALPPS procedure? A new technical note.
    Eur J Surg Oncol. 2015;41:1556-7.
    PubMed     Text format    


  53. TRUANT S, Pruvot FR
    Is there still a room to improve the safety of ALPPS procedure? A new technical note.
    Eur J Surg Oncol. 2015;41:1554-5.
    PubMed     Text format    


  54. ARAUJO RO, Valadao M, Borges D, Linhares E, et al
    Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study.
    Eur J Surg Oncol. 2015;41:1456-63.
    PubMed     Text format     Abstract available


  55. HOMAN J, Bokkerink GM, Aarts MJ, Lemmens VE, et al
    Variation in circumferential resection margin: Reporting and involvement in the South-Netherlands.
    Eur J Surg Oncol. 2015;41:1485-92.
    PubMed     Text format     Abstract available


  56. BONDEVEN P, Emmertsen KJ, Laurberg S, Pedersen BG, et al
    Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery.
    Eur J Surg Oncol. 2015;41:1493-9.
    PubMed     Text format     Abstract available


    October 2015
  57. BOOTH CM, Nanji S, Wei X, Biagi JJ, et al
    Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study.
    Eur J Surg Oncol. 2015 Oct 24. pii: S0748-7983(15)00828.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: